Bioray Biotech Co., Ltd

Bioray Biotech Co., Ltd

7561.TWO
Bioray Biotech Co., LtdTW flagTaipei Exchange
18.20
TWD
-0.65
- -
538.45MMarket Cap

Bioray Biotech Co., Ltd (7561.TWO) Stock Split History

Learn about Bioray Biotech Co., Ltd's most recent 41-for-40 basis stock split on July 28, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Bioray Biotech Co., Ltd's most recent stock split

Split Date: 2022-07-28
Split Ratio: 41:40
Price Before Split: $37.10
Price After Split: $36.20

Developer API

Get 7561.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/7561.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.02 times more shares (a 41:40 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Bioray Biotech Co., Ltd's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-07-2841:40No$37.10$36.20

About Bioray Biotech Co., Ltd

Company overview and industry information

Bioray Biotech Co., Ltd (7561.TWO) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 41-for-40 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Bioray Biotech Co., Ltd Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.